trastuzumab,tucatinib,temsirolimus,talazoparib,atezolizumab,abemaciclib,ipilimumab,palbociclib,sunitinib,pertuzumab,olaparib,vemurafenib,entrectinib,regorafenib,cobimetinib,nivolumab,futibatinib,larotrectinib,pembrolizumab
pfizer,bayer,roche,eli lilly,merck,otsuka,astrazeneca,bms,seagen
['tapur']
 yes tapur checks all the boxes!
Chief Medical Officer, American Society of Clinical Oncology (ASCO). Tweets are my own.